410 programming-"https:"-"Inserm"-"FEMTO-ST" "https:" "https:" "https:" "https:" "https:" "UCL" positions at University of Oxford
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
prepares to launch its public programme in April 2026, you will play a key role in shaping and delivering marketing campaigns that introduce the Centre, its programmes, spaces and wider public offer to new
-
health data assets, including data on wider determinants of health e.g. climate. As well as analyse data following pre-specified analysis plan/s and/or approved protocols. In this position you will lead
-
associated with a Tutorial Fellowship at St John’s College. This is an exciting opportunity to lead a world-class research programme in collider physics. The position is available from 1 September 2026
-
, insight and best-practice guidance to programme teams, senior stakeholders, agency partners and colleagues across Digital Marketing. Produce and present clear, data-led performance reporting and
-
The Faculty of Asian and Middle Eastern Studies aims to appoint a Career Development Fellowship in Hebrew Studies, funded by the Kennicott Fund for two years, to plan and deliver a research project
-
Applications are invited for a trial administrator to work with a team working with Professor Susan Jebb on a research programme within the Health Behaviours team. The team focus is on improving
-
thrusts within the lab’s multi-agent security programme. You should possess a completed PhD/DPhil (or thesis submitted by the start date) in Computer Science, Machine Learning, AI, Security, Robotics
-
aspirations. Through Opportunity Oxford, selected Oxford offer-holders participate in an academic programme which supports them in their transition from school or college to the university. This ambitious
-
Are you an experienced programme or portfolio office lead in capital projects or construction delivery who wants to make a real difference? Join our Estates Department at the University of Oxfordas
-
an active programme of phase I, II, clinical trials across the UK, and Gambia, Burkina Faso and Kenya, working closely with international partners to evaluate vaccine safety, immune responses. We are now